Spirometry is used
to classify patients into GOLD stages
1 to 4 according to the severity of
airflow limitation, as determined by the forced expiratory volume in one
second (FEV1), while assessment of
patients’ risk of COPD exacerbations
is based on their exacerbation
history. Table 1 summarizes characteristics
associated with each patient
group.